Literature DB >> 19400689

Bats in the bedroom, bats in the belfry: reanalysis of the rationale for rabies postexposure prophylaxis.

Gaston De Serres1, Danuta M Skowronski, Pierre Mimault, Manale Ouakki, Renée Maranda-Aubut, Bernard Duval.   

Abstract

BACKGROUND: We assessed the scientific basis and practical implications of recommendations made since the late 1990s to offer rabies postexposure prophylaxis (RPEP) for occult bat encounters, including recommendations to offer RPEP to persons with bedroom exposure to a bat while sleeping without evidence of direct physical contact.
METHODS: The number needed to treat after bedroom exposure to a bat was calculated as the percentage of population exposed multiplied by the inverse of crude rabies incidence. Bedroom exposure was estimated in a population survey of 14,453 households. Incidence was based on reported human cases in Canada and the United States, 1990-2007.
RESULTS: In the population surveyed, bedroom bat exposure while sleeping and without known physical contact occurred at an annual rate of 0.099%. We estimate that <5% of eligible persons with bedroom exposure receive RPEP as recommended. The incidence of human rabies due to bedroom bat exposure without recognized contact was 1 case per 2.7 billion person-years. The number needed to treat to prevent a single case of human rabies in that context ranges from 314,000 to 2.7 million persons. A total of 293-2500 health care professionals working full-time for a full year would be required to prevent a single human case of bat rabies due to bedroom exposure without recognized contact. Amounts of Can $228 million to Can $2.0 billion are additionally required for associated material costs.
CONCLUSIONS: Human rabies acquired through bedroom exposure to a bat while sleeping and without recognized contact is rare. Conversely, such exposures are not uncommon in the population, and the resources required for associated RPEP are orders of magnitude higher than those required for most interventions that are considered to be reasonable. Current RPEP recommendations related to occult bat contact should be reconsidered.

Entities:  

Mesh:

Year:  2009        PMID: 19400689     DOI: 10.1086/598998

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  Public health: Exposure to bats: updated recommendations.

Authors:  Bryna Warshawsky; Shalini Desai
Journal:  CMAJ       Date:  2009-12-14       Impact factor: 8.262

2.  Clinical pearls in infectious diseases.

Authors:  Randall S Edson; John B Bundrick; Scott C Litin
Journal:  Mayo Clin Proc       Date:  2011-03       Impact factor: 7.616

3.  Exposure to rabies during pregnancy.

Authors:  Catherine Windrim; Allison J McGeer; Kellie E Murphy
Journal:  CMAJ       Date:  2018-10-29       Impact factor: 8.262

4.  Effect of media warnings on rabies postexposure prophylaxis, France.

Authors:  Philippe Gautret; Caroline Labreuil; Mohamadou Seyni; Jean Delmont; Philippe Parola; Philippe Brouqui
Journal:  Emerg Infect Dis       Date:  2011-06       Impact factor: 6.883

5.  Bat rabies in Massachusetts, USA, 1985-2009.

Authors:  Xingtai Wang; Alfred DeMaria; Sandra Smole; Catherine M Brown; Linda Han
Journal:  Emerg Infect Dis       Date:  2010-08       Impact factor: 6.883

Review 6.  A review of the circumstances and health-seeking behaviours associated with bat exposures in high-income countries.

Authors:  Eryn Wright; Satyamurthy Anuradha; Russell Richards; Simon Reid
Journal:  Zoonoses Public Health       Date:  2022-06-13       Impact factor: 2.954

Review 7.  A Systematic Review of Human Bat Rabies Virus Variant Cases: Evaluating Unprotected Physical Contact with Claws and Teeth in Support of Accurate Risk Assessments.

Authors:  Virginia M Dato; Enzo R Campagnolo; Jonah Long; Charles E Rupprecht
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

8.  Bat rabies in Washington State: Temporal-spatial trends and risk factors for zoonotic transmission (2000-2017).

Authors:  Jesse Bonwitt; Hanna Oltean; Misty Lang; Rochelle M Kelly; Marcia Goldoft
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.